Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...

The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

But sales of Spiriva, approved in chronic obstructive pulmonary disease and asthma, have declined by almost 15% although it is still BI’s biggest drug, generating sales of around 3 billion euros.

The firm stated that the stock is already pricing the one-off benefits of its blockbuster respiratory drug Spiriva in FY25 and FY26. Aside from that, the brokerage also remarked that ...

This reduces the amount of drug deposited on your cheeks ... like Seebri Respimat and Spiriva Respimat. Asthma inhaler differ ...

They are also used as add-on therapy for asthma maintenance in the case of Spiriva. There is also a combination inhaler called Combivent that contains albuterol, a SABA, and the anticholinergic drug ...

The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it ...

The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...